Live mpox (monkeypox) statistics for Iran, updated automatically from World Health Organization surveillance data.
First case 18 Aug 2022 · latest WHO report 30 Dec 2025 · updates automatically
As of 27 September 2026, Iran has reported 4 confirmed mpox (monkeypox) cases and 0 deaths to the World Health Organization, with the first confirmed case recorded on 18 August 2022. That is the 115th highest total worldwide and the 23rd in Asia. The rate is 0.0 cases per million people (below the world average of 23.6). No new confirmed cases have been reported in the last six months.
Total confirmed cases: Iran
Cumulative confirmed cases by report date
Iran: 4 confirmed cases.
New confirmed cases: Iran
By month of report to WHO
Iran: 0 cases in the last 90 days.
Latest reports: Iran
Most recent submissions to WHO
Loading…
Mpox in Iran: frequently asked questions
How many mpox cases are there in Iran?
Iran has reported 4 laboratory-confirmed mpox (monkeypox) cases to WHO as of 27 September 2026, the 115th highest total of 145 countries with cases.
How many people have died from mpox in Iran?
No mpox deaths have been confirmed in Iran in the data reported to WHO.
Are mpox cases rising in Iran?
No new confirmed cases have been reported in the last six months. The latest report to WHO is dated 30 December 2025.
Has clade Ib mpox been found in Iran?
Clade Ib has not been reported for Iran in WHO situation reports so far. Cases there have been clade II or clade Ia. The worldwide list of clade Ib countries is on the main tracker page.
When was the first mpox case in Iran?
The first confirmed case in WHO data for Iran was recorded on 18 August 2022.
How does Iran compare with other countries?
Iran has 0.0 confirmed cases per million people, against a world average of 23.6. It ranks 23rd in Asia by total cases.
How can I protect myself from mpox?
Avoid close, skin-to-skin contact with people who have a rash that looks like mpox, do not share bedding, towels or utensils with someone who is sick, and wash hands often. Vaccination with MVA-BN is recommended for people at higher risk; check with local health services in Iran for availability.